As there was significant regulation of DPM2 gene alternative splicing in mitosis and ENST00000314392 showed a significant correlation with mitosis-related drug sensitivity, we believe that DPM2 may have a biological role in breast cancer progression. Here, DPM2 is linked to breast carcinoma.